We found that the risks for breast and ovarian cancers in the female relatives of BRCA1 and BRCA2 carriers were significantly higher than non-carriers, and the risks for pancreatic and prostate cancers in male relatives of BRCA2 carriers were also significantly increased. This evidence concerns the gene BRCA2 and Familial prostate cancer.